Assembly Biosciences, Inc.
Cash Flow Statement
| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-11.2M | $-9.1M | $-11.0M | $-14.4M | $-16.9M | $-19.0M | $-22.4M | $-23.1M |
| Depreciation & Amortization | $32.0K | $32.0K | $84.0K | $116.0K | $126.0K | $124.0K | $124.0K | $134.0K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $833.0K | $739.0K | $959.0K | $1.1M | $1.2M | $1.8M | $2.0M | $1.6M |
| Net Cash from Operating Activities | $-17.1M | $-18.4M | $73.6M | $-13.8M | $-13.6M | $-23.4M | $-19.3M | $-19.8M |
| Investing Activities | ||||||||
| Capital Expenditures | $14.0K | $14.0K | $71.0K | $136.0K | $48.0K | $0 | $0 | $102.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $5.1M | $17.3M | $-89.7M | $18.9M | $-8.4M | $10.0M | $16.6M | $31.4M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $12.5M | $0 | $9.2M | $0 | $134.0K | $4.5M | $437.0K | $0 |
| Net Change in Cash | $459.0K | $-1.1M | $-6.8M | $5.0M | $-21.9M | $-8.9M | $-2.3M | $11.6M |
| Free Cash Flow | $-17.1M | $-18.4M | $73.6M | $-14.0M | $-13.7M | $-23.4M | $-19.3M | $-19.9M |